AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy
The model may help clinicians identify patients who would benefit from disease-specific therapies or enrollment into clinical trials.
Source: pharmacytimes.com